Company Filing History:

6 out of 2,198

Smithkline Beecham Corporation

patents

6 out of 1,168

Glaxo Group Limited

patents

Years Active: 2004-2011

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7919507 - N-aroyl cyclic amines (2011-04-05),

2. 7790758 - Compounds which potentiate glutamate receptor and uses thereof in medicine (2010-09-07),

3. 7741351 - Compounds which potentiate glutamate receptor and uses thereof in medicine (2010-06-22),

4. 7741329 - N-aroyl cyclic amines (2010-06-22),

5. 7642256 - Compounds which potentiate AMPA receptor and uses thereof in medicine (2010-01-05),

6. 7618969 - Compounds which potentiate glutamate receptor and uses thereof in medicine (2009-11-17),

7. 7572819 - Compounds which potentiate glutamate receptor and uses thereof in medicine (2009-08-11),

8. 7566735 - Compounds which potentiate AMPA receptor and uses thereof in medicine (2009-07-28),

9. 7432270 - N-aroyl cyclic amines (2008-10-07),

10. 6943160 - Morpholine derivatives as antagonists of orexin receptors (2005-09-13),

11. 6939871 - Benzoxazinone derivatives, their preparation and use (2005-09-06),

12. 6677354 - Piperdines for use as orexin receptor antagonists (2004-01-13),

Title: Kevin Thewlis: Innovator in Pharmaceutical Chemistry

Introduction

Kevin Thewlis is a notable inventor based in Harlow, GB, recognized for his contributions to pharmaceutical chemistry. With a total of 12 patents to his name, he has made significant advancements in the field, particularly in the development of novel compounds for medical applications.

Latest Patents

Among his latest patents, Thewlis has developed N-aroyl cyclic amines, which are derivatives that have potential use as pharmaceuticals. These compounds are characterized by specific substituent variables, as defined in his patent documentation. Another significant invention relates to compounds that potentiate the glutamate receptor, which are crucial for treating various diseases and conditions mediated by this receptor. The invention includes compositions containing these derivatives and outlines processes for their preparation.

Career Highlights

Throughout his career, Kevin Thewlis has worked with prominent companies in the pharmaceutical industry, including SmithKline Beecham Corporation and Glaxo Group Limited. His work in these organizations has allowed him to contribute to the development of innovative medical solutions.

Collaborations

Thewlis has collaborated with notable colleagues, including Christopher Norbert Johnson and Geoffrey Stemp, enhancing the impact of his research and inventions.

Conclusion

Kevin Thewlis stands out as a significant figure in the realm of pharmaceutical innovation, with a strong portfolio of patents that reflect his expertise and dedication to improving medical treatments. His work continues to influence the field and offers promising avenues for future research and development.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.